Work

Crossing the Blood-Brain Barrier for Neuroprotection: A Conceptual Review and Therapeutic Hypothesis on Exosome-Mediated Neuroglobin (NGB) Delivery in Alzheimer's and Parkinson's Diseases

Year: 2026
Type: preprint
Abstract: Neurodegenerative disorders, particularly Alzheimer’s disease (AD) and Parkinson’s disease (PD), represent an escalating global health crisis characterized by progressive neuronal loss, oxidative stress, mitochondrial dysfunction, and pathological protein aggregation. Neuroglobin (NGB), an endogenous oxygen-binding heme protein predominantly expressed in central and peripheral neurons, plays a vital neuroprotective role by scavenging reactive oxygen and nitrogen species, preserving mitochondrial bioenergetics, and inhibiting intrinsic apoptotic pathways. However, clinical observations indicate that while NGB is transiently upregulated during early neurodegeneration as a compensatory response, its expression declines precipitously in advanced stages of AD and PD. To overcome the selective blood-brain barrier (BBB) and rapid systemic degradation of recombinant proteins, this conceptual review introduces two novel therapeutic frameworks: the Phyto-Exosomal Hybrid Neuroglobin System (PES-NGB), utilizing scalable plant-derived nanovesicles functionalized with neuron-homing rabies virus glycoprotein (RVG) peptides for non-invasive intranasal delivery; and the Redox-Gated Self-Amplifying Neuroglobin Circuit (RG-SANC), a circular RNA-based genetic switch engineered to restrict NGB synthesis exclusively to oxidatively stressed neurons. Furthermore, this article outlines a three-phase outpatient clinical protocol and a low-cost translational roadmap to make NGB-based neurotherapeutics accessible in resource-limited healthcare settings.
Language: English
Open Access status: green
OpenAlex ID: W7236036775
Cites:
Cited by:
Related to: 10